Abstract:Streptococcus dysgalactiae spp. dysgalactiae is an important causative agent of bovine mastitis worldwide. Lactoferrin is an innate immune protein that is associated with many functions including immunomodulatory, antiproliferative and antimicrobial properties. This study aimed to investigate the interactions between lactoferrin and a clinical bovine mastitis isolate, S. dysgalactiae spp. dysgalactiae DPC5345. Initially a deliberate in vivo bovine intramammary challenge was performed with S. dysgalactiae DPC53… Show more
“…The protein has antimicrobial properties as it binds iron, which is essential for bacterial and viral replication [ 42 ]. Since iron demand of streptococcal species is rather low, lactoferrin was demonstrated to have a bacteriostatic effect on different streptococci [ 43 ]. Clinical trials attempted on seven Holstein Friesian cows showed that 67% of the mammary quarters infected with S. uberis wild-type showed clinical manifestations of mastitis (clots in produced milk, firm and moderate swelling of the mammary glands with red coloration).…”
Section: Pathogenesis and Virulence Factorsmentioning
confidence: 99%
“…After 8 h of exposure to lactoferrin, a dose-dependent growth inhibition of S. dysgalactiae was observed in a previous study due to the antimicrobial properties of the protein. In addition, assays conducted with HC-11 murine epithelial cells revealed lactoferrin-dependent decrease of bacterial adhesion [ 43 ]. Lactoferrin may serve as a bridging molecule for S. uberis , consequently promoting adherence and internalization into mammary epithelial cells, thereby surviving host defense mechanisms by immune evasion [ 46 ].…”
Section: Pathogenesis and Virulence Factorsmentioning
The Streptococcus genus belongs to one of the major pathogen groups inducing bovine mastitis. In the dairy industry, mastitis is the most common and costly disease. It not only negatively impacts economic profit due to milk losses and therapy costs, but it is an important animal health and welfare issue as well. This review describes a classification, reservoirs, and frequencies of the most relevant Streptococcus species inducing bovine mastitis (S. agalactiae, S. dysgalactiae and S. uberis). Host and environmental factors influencing mastitis susceptibility and infection rates will be discussed, because it has been indicated that Streptococcus herd prevalence is much higher than mastitis rates. After infection, we report the sequence of cow immune reactions and differences in virulence factors of the main Streptococcus species. Different mastitis detection techniques together with possible conventional and alternative therapies are described. The standard approach treating streptococcal mastitis is the application of ß-lactam antibiotics. In streptococci, increased antimicrobial resistance rates were identified against enrofloxacin, tetracycline, and erythromycin. At the end, control and prevention measures will be considered, including vaccination, hygiene plan, and further interventions. It is the aim of this review to estimate the contribution and to provide detailed knowledge about the role of the Streptococcus genus in bovine mastitis.
“…The protein has antimicrobial properties as it binds iron, which is essential for bacterial and viral replication [ 42 ]. Since iron demand of streptococcal species is rather low, lactoferrin was demonstrated to have a bacteriostatic effect on different streptococci [ 43 ]. Clinical trials attempted on seven Holstein Friesian cows showed that 67% of the mammary quarters infected with S. uberis wild-type showed clinical manifestations of mastitis (clots in produced milk, firm and moderate swelling of the mammary glands with red coloration).…”
Section: Pathogenesis and Virulence Factorsmentioning
confidence: 99%
“…After 8 h of exposure to lactoferrin, a dose-dependent growth inhibition of S. dysgalactiae was observed in a previous study due to the antimicrobial properties of the protein. In addition, assays conducted with HC-11 murine epithelial cells revealed lactoferrin-dependent decrease of bacterial adhesion [ 43 ]. Lactoferrin may serve as a bridging molecule for S. uberis , consequently promoting adherence and internalization into mammary epithelial cells, thereby surviving host defense mechanisms by immune evasion [ 46 ].…”
Section: Pathogenesis and Virulence Factorsmentioning
The Streptococcus genus belongs to one of the major pathogen groups inducing bovine mastitis. In the dairy industry, mastitis is the most common and costly disease. It not only negatively impacts economic profit due to milk losses and therapy costs, but it is an important animal health and welfare issue as well. This review describes a classification, reservoirs, and frequencies of the most relevant Streptococcus species inducing bovine mastitis (S. agalactiae, S. dysgalactiae and S. uberis). Host and environmental factors influencing mastitis susceptibility and infection rates will be discussed, because it has been indicated that Streptococcus herd prevalence is much higher than mastitis rates. After infection, we report the sequence of cow immune reactions and differences in virulence factors of the main Streptococcus species. Different mastitis detection techniques together with possible conventional and alternative therapies are described. The standard approach treating streptococcal mastitis is the application of ß-lactam antibiotics. In streptococci, increased antimicrobial resistance rates were identified against enrofloxacin, tetracycline, and erythromycin. At the end, control and prevention measures will be considered, including vaccination, hygiene plan, and further interventions. It is the aim of this review to estimate the contribution and to provide detailed knowledge about the role of the Streptococcus genus in bovine mastitis.
“…Bacteriocins such as nisin A have demonstrated antibacterial activity against mastitis pathogens ( Malvisi et al, 2016 ). Immune stimulants such as ginseng ( Beccaria et al, 2018 ) and the use of plant-derived compounds ( Maia et al, 2018 ) and immune proteins such as lactoferrin ( O’Halloran et al, 2016 ) have also been tested in this regard. Probiotic lactic acid bacteria (LAB) strains have been reported to eliminate mastitis-causing staphylococcal biofilms ( Wallis et al, 2019 ).…”
Bovine mastitis is a disease with a multi-etiological nature, defined as an infection and inflammation of the udder. Mastitis represents a significant ongoing concern in the dairy industry, leading to substantial losses in profits and revenue for farmers worldwide. The predominant causes of bovine mastitis include the pathogens Staphylococcus aureus, Streptococcus dysgalactiae, Streptococcus uberis, and Escherichia coli. Antibiotic administration is currently the main treatment option for mastitis. However, there is a pressing need for alternative therapies to treat and prevent the disease, especially with the emergence of antibiotic-resistant, mastitis-causing pathogens, resulting in antibiotic treatment failure. One such example is live bio-therapeutics (also known as probiotics), such as Lactococcus lactis DPC3147. The efficacy of this live bio-therapeutic has been demonstrated in several previous trials by our group. The most recent of these trials showed that an emulsion-based formulation of this strain was as effective as a commercial antibiotic formulation in treating sub-clinical and clinical cases of bovine mastitis. Here, we report the results of a follow-up field trial, in which we sought to gain insight into the mechanism of action of such live bio-therapeutics, focussing on chronic mastitis cases. We treated 28 cows with chronic mastitis with two separate emulsion-based formulations containing either viable L. lactis DPC3147 cells (15 cows) or heat-killed L. lactis DPC3147 cells (13 cows). We then evaluated the efficacies of the two formulations (two treatment groups) in terms of stimulating a localized immune response (quantified by measuring IL-8 concentrations in milk collected from udders affected by mastitis) and efficacies in terms of cure rates (quantified by reductions in somatic cell counts and absence of pathogens). We demonstrate that the presence of heat-inactivated bacteria (a postbiotic) was as effective as the live bio-therapeutic in eliciting a localized immune response in cows with chronic mastitis. The response to heat-killed cells (postbiotic) reported herein could have beneficial implications for farmers with regard to prolonging the shelf life of such emulsion-based formulations containing heat-killed cells of L. lactis DPC3147 for curing cows with mastitis.
“…Streptococcus is a bacterium that is often found in mastitis, including S. agalactiae, S. dysgalactiae, and S. uberis [4,5]. One of the virulence factors in streptococcus is a lactoferrin-binding protein (LBP), but there are differences among these organisms, especially the pathogenesis of milk lactoferrin protein to interact with streptococcus [6]. Lactoferrin is a host innate immune protein that acts as antibacterial, immunomodulator, antiadhesion, and has iron-binding properties [7,8,9].…”
Bovine mastitis is an udder inflammation mostly found in dairy cattle that causes enormous economic losses. Streptococcus is a bacterium that is often found in mastitis, including Streptococcus agalactiae, Streptococcus dysgalactiae, and Streptococcus uberis. These three species have lactoferrinbinding protein (LBP) as one of their virulence factors. Lactoferrin is a host innate immune protein that acts as antibacterial, immunomodulator, anti-adhesion, and has iron-binding properties. The LBP on the surface of Streptococcus could bind to lactoferrin produced by host cells. Uniquely, the three Streptococcus bacteria showed different responses to lactoferrin. The lactoferrin-LBP bound on S. agalactiae and S. dysgalactiae was known to inhibit their penetration ability into the host epithelial cells, on the contrary, in S. uberis it could enhance their ability to invade the cells. This paper aims to review the role of the lactoferrin-binding protein of Streptococcus in bovine mastitis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.